Homeostasis model assessment: insulin resistance and ?-cell function from fasting plasma glucose and insulin concentrations in man

Matthews, D. R., Hosker, J. P., Rudenski, A. S., Naylor, B. A., Treacher, D. F., Turner, R. C.·1985·Diabetologia

Cited by (31,472)

Items 301–400 of 31,472

  1. Obesity as a multisystem disease: Trends in obesity rates and obesity‐related complications
    Shohinee Sarma, Sanjeev Sockalingam, Satya Dash · 2021 · Diabetes Obesity and Metabolism
  2. Improvement of Early Vascular Changes and Cardiovascular Risk Factors in Obese Children After a Six-Month Exercise Program
    Andreas Alexander Meyer, Günther Kundt, Ute Lenschow, Peter Schuff‐Werner, Wolfgang Kienast · 2006 · Journal of the American College of Cardiology
  3. Prevalence and Determinants of Insulin Resistance Among U.S. Adolescents
    Joyce M. Lee, Megumi J. Okumura, Matthew M. Davis, William H. Herman, James G. Gurney · 2006 · Diabetes Care
  4. Overfeeding polyunsaturated and saturated fat causes distinct effects on liver and visceral fat accumulation in humans
    Rosqvist, Fredrik, Iggman, David, Kullberg, Joel, Cedernaes, Jonathan, Johansson, Hans-Erik, Larsson, Anders, Johansson, Lars, Ahlström, Håkan, Arner, Peter, Dahlman, Ingrid et al. · 2014 · Diabetes
  5. Fatty Liver Is Associated With Dyslipidemia and Dysglycemia Independent of Visceral Fat: the Framingham Heart Study
    Elizabeth K. Speliotes, Joseph M. Massaro, Udo Hoffmann, Ramachandran Srini Vasan, James B. Meigs, Dushyant V. Sahani, Joel N. Hirschhorn, Christopher J. O’Donnell, Caroline S. Fox · 2010 · Hepatology
  6. Insulin resistance is associated with the pathology of Alzheimer disease: The Hisayama Study
    Matsuzaki, T., Sasaki, K., Tanizaki, Y., Hata, J., Fujimi, K., Matsui, Y., Sekita, A., Suzuki, S.O., Kanba, S., Kiyohara, Y. et al. · 2010 · Neurology
  7. Homeostasis Model Assessment Is a Reliable Indicator of Insulin Resistance During Follow-up of Patients With Type 2 Diabetes
    Akira Katsuki, Yasuhiro Sumida, Esteban Cesar Gabazza, Shuichi Murashima, Masahiko Furuta, Rika Araki-Sasaki, Yasuko Hori, Yutaka Yano, Yukihiko Adachi · 2001 · Diabetes Care
  8. MINMOD Millennium: A Computer Program to Calculate Glucose Effectiveness and Insulin Sensitivity from the Frequently Sampled Intravenous Glucose Tolerance Test
    Ray Boston, Darko Stefanovski, Peter J. Moate, Anne E. Sumner, Richard M. Watanabe, Richard N. Bergman · 2003 · Diabetes Technology & Therapeutics
  9. Impact of Weight Loss on Inflammatory Proteins and Their Association With the Insulin Resistance Syndrome in Morbidly Obese Patients
    Kopp, H.P., Kopp, C.W., Festa, A., Krzyzanowska, K., Kriwanek, S., Minar, E., Roka, R., Schernthaner, G. · 2003 · Arteriosclerosis, Thrombosis, and Vascular Biology
  10. The effect of intermittent energy and carbohydrate restriction<i>v</i>. daily energy restriction on weight loss and metabolic disease risk markers in overweight women
    Harvie, Michelle, Wright, Claire, Pegington, Mary, McMullan, Debbie, Mitchell, Ellen, Martin, Bronwen, Cutler, Roy G., Evans, Gareth, Whiteside, Sigrid, Maudsley, Stuart et al. · 2013 · British Journal Of Nutrition
  11. Accuracy and reproducibility of transient elastography for the diagnosis of fibrosis in pediatric nonalcoholic steatohepatitis†
    Valério Nobili, Francesco Vizzutti, Umberto Arena, Juan G. Abraldeṣ, Fabio Marra, Andrea Pietrobattista, Rodolfo Fruhwirth, Matilde Marcellini, Massimo Pinzani · 2008 · Hepatology
  12. Oral Magnesium Supplementation Improves Insulin Sensitivity and Metabolic Control in Type 2 Diabetic Subjects
    Rodríguez-Morán, Martha, Guerrero-Romero, Fernando · 2003 · Diabetes Care
  13. A Haplotype at the Adiponectin Locus Is Associated With Obesity and Other Features of the Insulin Resistance Syndrome
    Claudia Menzaghi, Tonino Ercolino, Rosa Di Paola, Anders Hayden Berg, James H. Warram, Philipp E. Scherer, Vincenzo Trischitta, Alessandro Doria · 2002 · Diabetes
  14. One Week’s Treatment With the Long-Acting Glucagon-Like Peptide 1 Derivative Liraglutide (NN2211) Markedly Improves 24-h Glycemia and α- and β-Cell Function and Reduces Endogenous Glucose Release in Patients with Type 2 Diabetes
    Degn, Kristine B., Juhl, Claus B., Sturis, Jeppe, Jakobsen, Grethe, Brock, Birgitte, Chandramouli, Visvanathan, Rungby, Joergen, Landau, Bernard R., Schmitz, Ole · 2004 · Diabetes
  15. THE EFFECT OF VITAMIN D3 ON INSULIN SECRETION AND PERIPHERAL INSULIN SENSITIVITY IN TYPE 2 DIABETIC PATIENTS
    A-M. Borissova, Tsvetalina I. Tankova, Georgi Кirilov, Lilia N. Dakovska, Roussanka Dimitrova Kovatcheva · 2003 · International Journal of Clinical Practice
  16. Insulin Resistance, the Metabolic Syndrome, and Risk of Incident Cardiovascular Disease in Nondiabetic American Indians
    Helaine E. Resnick, Kristina L. Jones, Giacomo Ruotolo, Arvind Kumar Jain, Jeffrey A. Henderson, Weiquan Lu, Barbara V. Howard · 2003 · Diabetes Care
  17. Effect of Initial Combination Therapy With Sitagliptin, a Dipeptidyl Peptidase-4 Inhibitor, and Metformin on Glycemic Control in Patients With Type 2 Diabetes
    L. Kennedy · 2008 · Yearbook of Endocrinology
  18. Trunk Fat and Leg Fat Have Independent and Opposite Associations With Fasting and Postload Glucose Levels
    Marieke Brigitte Snijder, Jacqueline M. Dekker, Marjolein Visser, L.M. Bouter, Coen D.A. Stehouwer, John S Yudkin, Robert J. Heine, Giel Nijpels, Jacob C. Seidell · 2004 · Diabetes Care
  19. Acute and long-term disruption of glycometabolic control after SARS-CoV-2 infection
    Laura Bacchelli Montefusco, Moufida Ben Nasr, Francesca D’Addio, Cristian Loretelli, Antonio Rossi, Ida Pastore, Giuseppe Daniele, Ahmed Abdelsalam, Anna Maestroni, Marco Dell’Acqua et al. · 2021 · Nature Metabolism
  20. Prevalence and risk factors of non‐alcoholic fatty liver disease among Korean adults
    SEUNG H PARK, Woo Kyu Jeon, SANG H KIM, Hong J. Kim, Dong Il Park, Yong K. Cho, In Kyung Sung, Chong Il Sohn, Dong Keuk Keum, BYUNG I KIM · 2006 · Journal of Gastroenterology and Hepatology
  21. Ninety patients with nonalcoholic steatohepatitis: insulin resistance, familial tendency, and severity of disease
    Ira R. Willner, Bradford Waters, S. Raj Patil, Adrian Reuben, Joseph Morelli, Caroline A. Riely · 2001 · The American Journal of Gastroenterology
  22. Alanine aminotransferase predicts coronary heart disease events: A 10-year follow-up of the Hoorn Study
    Roger K. Schindhelm, Jacqueline M. Dekker, Giel Nijpels, L.M. Bouter, Coen D.A. Stehouwer, Robert J. Heine, Michaëla Diamant · 2006 · Atherosclerosis
  23. Skeletal muscle as an endocrine organ: PGC-1α, myokines and exercise
    Schnyder, Svenia, Handschin, Christoph · 2015 · Bone
  24. Effects of Roux-en-Y Gastric Bypass Surgery on Fasting and Postprandial Concentrations of Plasma Ghrelin, Peptide YY, and Insulin
    Korner, Judith, Bessler, Marc, Cirilo, L. J., Conwell, Irene M., Daud, Amna, Restuccia, Nancy L., Wardlaw, Sharon L. · 2005 · The Journal of Clinical Endocrinology &amp; Metabolism
  25. A common Greenlandic TBC1D4 variant confers muscle insulin resistance and type 2 diabetes
    Moltke, Ida, Grarup, Niels, Jørgensen, Marit E., Bjerregaard, Peter, Treebak, Jonas T., Fumagalli, Matteo, Korneliussen, Thorfinn S., Andersen, Marianne A., Nielsen, Thomas S., Krarup, Nikolaj T. et al. · 2014 · Nature
  26. The Efficacy and Safety of Saxagliptin When Added to Metformin Therapy in Patients With Inadequately Controlled Type 2 Diabetes With Metformin Alone
    DeFronzo, Ralph A., Hissa, Miguel N., Garber, Alan J., Luiz Gross, Jorge, Yuyan Duan, Raina, Ravichandran, Shoba, Chen, Roland S., for the Saxagliptin 014 Study Group · 2009 · Diabetes Care
  27. Association of Insulin Resistance With Cerebral Glucose Uptake in Late Middle–Aged Adults at Risk for Alzheimer Disease
    Willette, Auriel A., Bendlin, Barbara B., Starks, Erika J., Birdsill, Alex C., Johnson, Sterling C., Christian, Bradley T., Okonkwo, Ozioma C., La Rue, Asenath, Hermann, Bruce P., Koscik, Rebecca L. et al. · 2015 · JAMA Neurology
  28. Synthesis, Structure–Activity Relationships, and in Vivo Efficacy of the Novel Potent and Selective Anaplastic Lymphoma Kinase (ALK) Inhibitor 5-Chloro-N2-(2-isopropoxy-5-methyl-4-(piperidin-4-yl)phenyl)-N4-(2-(isopropylsulfonyl)phenyl)pyrimidine-2,4-diamine (LDK378) Currently in Phase 1 and Phase 2 Clinical Trials
    Thomas H. Marsilje, Wei Pei, Bei Chen, Wenshuo Lu, Tetsuo Uno, Yunho Jin, Tao Jiang, Sungjoon Kim, Nanxin Li, Markus Warmuth et al. · 2013 · Journal of Medicinal Chemistry
  29. Oxidative Stress Is Associated with Adiposity and Insulin Resistance in Men
    Hideki Urakawa, Akira Katsuki, Yasuhiro Sumida, Esteban Cesar Gabazza, Shuichi Murashima, Kohei Morioka, Noriko Maruyama, Nagako Kitagawa, Takashi Tanaka, Yasuko Hori et al. · 2003 · The Journal of Clinical Endocrinology & Metabolism
  30. Lifestyle intervention and antioxidant therapy in children with nonalcoholic fatty liver disease
    Valério Nobili, Melania Manco, Rita De Vito, Vincenzo Maria Di Ciommo, Donatella Comparcola, Maria Rita Sartorelli, Fiorella Piemonte, Matilde Marcellini, Paul Angulo · 2008 · Hepatology
  31. The New BMI Criteria for Asians by the Regional Office for the Western Pacific Region of WHO are Suitable for Screening of Overweight to Prevent Metabolic Syndrome in Elder Japanese Workers
    Erdembileg Anuurad, Kuninori Shiwaku, Akiko Nogi, Keiko Kitajima, Byambaa Enkhmaa, K Shimono, Yosuke Yamane · 2003 · Journal of Occupational Health
  32. Metabolic clustering of risk factors: evaluation of Triglyceride-glucose index (TyG index) for evaluation of insulin resistance
    Sikandar Hayat Khan, Farah Sobia, Najmusaqib Khan Niazi, Syed Mohsin Manzoor, Nadeem Fazal, Fowad Ahmad · 2018 · Diabetology & Metabolic Syndrome
  33. Relationship Between Serum Uric Acid Concentration and Insulin Resistance and Metabolic Syndrome
    Tae Woo Yoo, Ki‐Chul Sung, Hun Sub Shin, Byung Jin Kim, Bum Soo Kim, Jin Ho Kang, Man Ho Lee, Jung Ro Park, Hyang Yeon Kim, Eun‐Jung Rhee et al. · 2005 · Circulation Journal
  34. Preterm Birth and the Metabolic Syndrome in Adult Life: A Systematic Review and Meta-analysis
    James R.C. Parkinson, Matthew James Hyde, Chris Gale, Shalini Santhakumaran, Neena Modi · 2013 · PEDIATRICS
  35. Bacterial Endotoxin Activity in Human Serum Is Associated With Dyslipidemia, Insulin Resistance, Obesity, and Chronic Inflammation
    M. Lassenius, K. Pietiläinen, K. Kaartinen, P. Pussinen, J. Syrjänen, C. Forsblom, I. Pörsti, A. Rissanen, J. Kaprio, J. Mustonen et al. · 2011 · Diabetes Care
  36. Adiponectin and its receptors in non-alcoholic steatohepatitis
    Susanne Kaser, Alexander Rupert Moschen, A Cayon, A Kaser, J Crespo, F Pons-Romero, Christoph F. Ebenbichler, J R Patsch, H Tilg · 2004 · Gut
  37. Effect of CPAP on insulin resistance and HbA1c in men with obstructive sleep apnoea and type 2 diabetes
    West, S. D, Nicoll, D. J, Wallace, T. M, Matthews, D. R, Stradling, J. R · 2007 · Thorax
  38. Berberine improves glucose metabolism through induction of glycolysis
    Jun Yin, Zhan‐Guo Gao, Dong Liu, Zhijun Liu, Jianping Ye · 2007 · American Journal of Physiology-Endocrinology and Metabolism
  39. Early evidence of ethnic differences in cardiovascular risk: cross sectional comparison of British South Asian and white children
    Peter Hynes Whincup · 2002 · BMJ
  40. Validation of simple indexes to assess insulin sensitivity during pregnancy in Wistar and Sprague-Dawley rats
    J. Cacho, Julio Sevillano, J. de Castro, Emílio Herrera, Pilar Ramos · 2008 · American Journal of Physiology-Endocrinology and Metabolism
  41. Plasma Adiponectin in Nonalcoholic Fatty Liver Is Related to Hepatic Insulin Resistance and Hepatic Fat Content, Not to Liver Disease Severity
    Elisabetta Bugianesi, Uberto Pagotto, Rita Manini, Ester Vanni, Amalia Gastaldelli, Rosaria DE IASIO, Elena Gentilcore, Stefania Natale, Maurizio Cassader, Mario Rizzetto et al. · 2005 · The Journal of Clinical Endocrinology & Metabolism
  42. Altered Insulin Signaling in Alzheimer’s Disease Brain – Special Emphasis on PI3K-Akt Pathway
    Gabbouj, Sami, Ryhänen, Simo, Marttinen, Mikael, Wittrahm, Rebekka, Takalo, Mari, Kemppainen, Susanna, Martiskainen, Henna, Tanila, Heikki, Haapasalo, Annakaisa, Hiltunen, Mikko et al. · 2019 · Frontiers in Neuroscience
  43. Association between Serum Osteocalcin and Markers of Metabolic Phenotype
    Anastassios G. Pittas, Susan S. Harris, Myrto Eliades, Paul C. Stark, Bess F. Dawson-Hughes · 2008 · The Journal of Clinical Endocrinology & Metabolism
  44. The selective androgen receptor modulator GTx‐024 (enobosarm) improves lean body mass and physical function in healthy elderly men and postmenopausal women: results of a double‐blind, placebo‐controlled phase II trial
    Dalton, James T., Barnette, Kester G., Bohl, Casey E., Hancock, Michael L., Rodriguez, Domingo, Dodson, Shontelle T., Morton, Ronald A., Steiner, Mitchell S. · 2011 · Journal of Cachexia, Sarcopenia and Muscle
  45. Patients with subclinical Cushing’s syndrome due to adrenal adenoma have increased cardiovascular risk
    Tauchmanovà, Libuse, Rossi, Riccardo, Biondi, Bernadette, Pulcrano, Melania, Nuzzo, Vincenzo, Palmieri, Emiliano-Antonio, Fazio, Serafino, Lombardi, Gaetano · 2002 · The Journal of Clinical Endocrinology &amp; Metabolism
  46. Increased prevalence of insulin resistance and nonalcoholic fatty liver disease in Asian-Indian men
    Petersen, Kitt Falk, Dufour, Sylvie, Feng, Jing, Befroy, Douglas, Dziura, James, Man, Chiara Dalla, Cobelli, Claudio, Shulman, Gerald I. · 2006 · Proceedings of the National Academy of Sciences
  47. Metformin in the treatment of patients with non‐alcoholic steatohepatitis
    Ahmet Uygun, Abdurrahman Kadayıfçı, Ahmet Turan Işık, T. Ozgurtas, S. Deveci, Ahmet Tüzün, Zeki Yeşilova, Mustafa Gülşen, Kemal Dağalp · 2004 · Alimentary Pharmacology & Therapeutics
  48. Synbiotic supplementation in nonalcoholic fatty liver disease: a randomized, double-blind, placebo-controlled pilot study
    Tannaz Eslamparast, Hossein Poustchi, Farhad Zamani, Maryam Sharafkhah, Reza Malekzadeh, Azita Hekmatdoost · 2014 · American Journal of Clinical Nutrition
  49. Synthetic Peroxisome Proliferator-Activated Receptor-γ Agonist, Rosiglitazone, Increases Plasma Levels of Adiponectin in Type 2 Diabetic Patients
    Wei‐Shiung Yang, Chi-Yuan Jeng, Ta-Jen Wu, Sachiyo Tanaka, Tohru Funahashi, Yūji Matsuzawa, Jao-Ping Wang, Chi‐Ling Chen, Tong‐Yuan Tai, Lee‐Ming Chuang · 2002 · Diabetes Care
  50. Endocrine and Metabolic Adverse Effects of Psychotropic Medications in Children and Adolescents
    Christoph Ulrich Correll, Harold E. Carlson · 2006 · Journal of the American Academy of Child & Adolescent Psychiatry
  51. Insulin Resistance Syndrome in Children
    Svetlana Ten, Noel Keith Maclaren · 2004 · The Journal of Clinical Endocrinology & Metabolism
  52. Cardiovascular Risk Factors and the Metabolic Syndrome in Pediatric Nonalcoholic Fatty Liver Disease
    Jeffrey B. Schwimmer, Perrie E. Pardee, Joel E. Lavine, Aaron K. Blumkin, Stephen R. Cook · 2008 · Circulation
  53. 2 years of calorie restriction and cardiometabolic risk (CALERIE): exploratory outcomes of a multicentre, phase 2, randomised controlled trial
    Kraus, William E, Bhapkar, Manjushri, Huffman, Kim M, Pieper, Carl F, Krupa Das, Sai, Redman, Leanne M, Villareal, Dennis T, Rochon, James, Roberts, Susan B, Ravussin, Eric et al. · 2019 · The Lancet Diabetes &amp; Endocrinology
  54. Insulin, Glucose, Insulin Resistance, and Pancreatic Cancer in Male Smokers
    Rachael Z. Stolzenberg‐Solomon · 2005 · JAMA
  55. Plasma Retinol-Binding Protein-4 Concentrations Are Elevated in Human Subjects With Impaired Glucose Tolerance and Type 2 Diabetes
    Young Min Cho, Byung‐Soo Youn, Hyewon Lee, Namseok Lee, Sung-Shik Min, Soo Heon Kwak, Hong Kyu Lee, Kyong Soo Park · 2006 · Diabetes Care
  56. Tauroursodeoxycholic Acid May Improve Liver and Muscle but Not Adipose Tissue Insulin Sensitivity in Obese Men and Women
    Marleen Kars, Ling Yang, Margaret F. Gregor, B. Selma Mohammed, Terri Pietka, Brian N. Finck, Bruce W. Patterson, Jay D. Horton, Bettina Mittendorfer, Gökhan S. Hotamışlıgil et al. · 2010 · Diabetes
  57. Cortisol Metabolism in Human Obesity: Impaired Cortisone→Cortisol Conversion in Subjects with Central Adiposity<sup>1</sup>
    Stewart, Paul M., Boulton, Abigail, Kumar, Sudhesh, Clark, Penny M. S., Shackleton, Cedric H. L. · 1999 · The Journal of Clinical Endocrinology &amp; Metabolism
  58. Human duodenal enteroendocrine cells: source of both incretin peptides, GLP-1 and GIP
    Michael J. Theodorakis, Olga D. Carlson, Spyridon Michopoulos, Maı̀re E. Doyle, Magdalena Juhaszova, Kalliopi Petraki, Josephine Mary Egan · 2005 · American Journal of Physiology-Endocrinology and Metabolism
  59. Insulin Resistance and Risk of Chronic Kidney Disease in Nondiabetic US Adults
    Jing Chen, Paul Muntner, L. Lee Hamm, Vivian Andrew Fonseca, Vecihi Batuman, Paul Kieran Whelton, Jiang He · 2003 · Journal of the American Society of Nephrology
  60. Cardiometabolic Risk in Patients With First-Episode Schizophrenia Spectrum Disorders: Baseline Results From the RAISE-ETP Study
    Correll, Christoph U., Robinson, Delbert G., Schooler, Nina R., Brunette, Mary F., Mueser, Kim T., Rosenheck, Robert A., Marcy, Patricia, Addington, Jean, Estroff, Sue E., Robinson, James et al. · 2014 · JAMA Psychiatry
  61. Metabolic syndrome in urban Asian Indian adults—a population study using modified ATP III criteria
    Ambady Ramachandran, Chamukuttan Snehalatha, K. Satyavani, Selvaraj Sivasankari, Vijay Viswanathan · 2003 · Diabetes Research and Clinical Practice
  62. Two Weeks of Reduced Activity Decreases Leg Lean Mass and Induces “Anabolic Resistance” of Myofibrillar Protein Synthesis in Healthy Elderly
    Breen, Leigh, Stokes, Keith A., Churchward-Venne, Tyler A., Moore, Daniel R., Baker, Stephen K., Smith, Kenneth, Atherton, Philip J., Phillips, Stuart M. · 2013 · The Journal of Clinical Endocrinology &amp; Metabolism
  63. Hyperglycemia and insulin resistance in men with prostate carcinoma who receive androgen‐deprivation therapy
    Shehzad Sultan Basaria, Denis C. Muller, Michael Anthony Carducci, Josephine Mary Egan, Adrian Sandra Dobs · 2005 · Cancer
  64. Nonalcoholic steatohepatitis
    Andrea Ewing Reid · 2001 · Gastroenterology
  65. Long-term resveratrol administration reduces metabolic disturbances and lowers blood pressure in obese Zucker rats
    Rivera, Leonor, Morón, Rocío, Zarzuelo, Antonio, Galisteo, Milagros · 2009 · Biochemical Pharmacology
  66. Health potential of polyols as sugar replacers, with emphasis on low glycaemic properties
    Geoffrey Livesey · 2003 · Nutrition Research Reviews
  67. Comparison of triglyceride-glucose index and HOMA-IR for predicting prevalence and incidence of metabolic syndrome
    Da‐Hye Son, Hye Sun Lee, Yong‐Jae Lee, Jun‐Hyuk Lee, Jee Hye Han · 2021 · Nutrition Metabolism and Cardiovascular Diseases
  68. The relative benefits of endurance and strength training on the metabolic factors and muscle function of people with type 2 diabetes mellitus
    Cauza, Edmund, Hanusch-Enserer, Ursula, Strasser, Barbara, Ludvik, Bernhard, Metz-Schimmerl, Sylvia, Pacini, Giovanni, Wagner, Oswald, Georg, Petra, Prager, Rudolf, Kostner, Karam et al. · 2005 · Archives of Physical Medicine and Rehabilitation
  69. Profound Perturbation of the Metabolome in Obesity Is Associated with Health Risk
    Elizabeth T. Cirulli, Lining Guo, Christine Leon Swisher, Naisha Shah, Lei Huang, Lori A. Napier, Ewen F. Kirkness, Tim D. Spector, C. Thomas Caskey, Bernard Thorens et al. · 2018 · Cell Metabolism
  70. Muscle Mass Index As a Predictor of Longevity in Older Adults
    Srikanthan, Preethi, Karlamangla, Arun S. · 2014 · The American Journal of Medicine
  71. Identification of Individuals With Insulin Resistance Using Routine Clinical Measurements
    Stern, Steven E., Williams, Ken, Ferrannini, Eleuterio, DeFronzo, Ralph A., Bogardus, Clifton, Stern, Michael P. · 2005 · Diabetes
  72. Clinical and psychological correlates of quality-of-life in polycystic ovary syndrome
    Hahn, Susanne, Janssen, Onno E, Tan, Susanne, Pleger, Katja, Mann, Klaus, Schedlowski, Manfred, Kimmig, Rainer, Benson, Sven, Balamitsa, Efthimia, Elsenbruch, Sigrid · 2005 · European Journal of Endocrinology
  73. Hepatic Steatosis: Quantification by Proton Density Fat Fraction with MR Imaging versus Liver Biopsy
    İlkay Sedakat İdilman, Hatice Aniktar, Ramazan Idılman, Gökhan Kabaçam, Berna Savaş, Atilla Halil Elhan, Azim Çelik, Kadir Bahar, Muşturay Karçaaltıncaba · 2013 · Radiology
  74. The genetics of type 2 diabetes: what have we learned from GWAS?
    Liana K. Billings, José C. Florez · 2010 · Annals of the New York Academy of Sciences
  75. The Polycystic Ovary Syndrome Associated with Morbid Obesity May Resolve after Weight Loss Induced by Bariatric Surgery
    Héctor Francisco Escobar-Morreale, José Ignacio Botella-Carretero, Francisco Álvarez‐Blasco, José Sancho, José L. San Millán · 2005 · The Journal of Clinical Endocrinology & Metabolism
  76. Nonalcoholic Fatty Liver Disease Is Associated With Carotid Atherosclerosis
    Ángel Brea, Daniel Mosquera, Eva Martin‐Solana, Ana Arizti, J.L. Cordero, Emilio Ros · 2005 · Arteriosclerosis Thrombosis and Vascular Biology
  77. Alanine Aminotransferase, γ-Glutamyltransferase, and Incident Diabetes
    Abigail Fraser, Ross Harris, Naveed A. Sattar, Shah B J Ebrahim, George Davey Smith, Debbie A. Lawlor · 2009 · Diabetes Care
  78. Cardiometabolic Differences in Children Born After in Vitro Fertilization: Follow-Up Study
    Manon Ceelen, Mirjam Maria van Weissenbruch, Jan P.W. Vermeiden, Flora E. van Leeuwen, Henriëtte A. Delemarre‐van de Waal · 2008 · The Journal of Clinical Endocrinology & Metabolism
  79. Intestinal Colonization by a Lachnospiraceae Bacterium Contributes to the Development of Diabetes in Obese Mice
    Keishi Kameyama, Kikuji Itoh · 2014 · Microbes and Environments
  80. Patients with neuroglycopenia after gastric bypass surgery have exaggerated incretin and insulin secretory responses to a mixed meal
    Goldfine, A. B., Mun, E. C., Devine, E., Bernier, R., Baz-Hecht, M., Jones, D. B., Schneider, B. E., Holst, J. J., Patti, M. E. · 2007 · The Journal of Clinical Endocrinology &amp; Metabolism
  81. Resveratrol Supplementation Does Not Improve Metabolic Function in Nonobese Women with Normal Glucose Tolerance
    Jun Yoshino, Caterina Conte, Luigi Fontana, Bettina Mittendorfer, Shin‐ichiro Imai, Kenneth B. Schechtman, C. Charles Gu, Iris Kunz, Filippo Rossi Fanelli, Bruce W. Patterson et al. · 2012 · Cell Metabolism
  82. Defining insulin resistance from hyperinsulinemic-euglycemic clamps
    Tam, Charmaine S., Xie, Wenting, Johnson, William D., Cefalu, William T., Redman, Leanne M., Ravussin, Eric · 2012 · Diabetes Care
  83. Predictors of Changes in Glucose Tolerance Status in Obese Youth
    Ram Weiss, Sara E. Taksali, William V. Tamborlane, Tania S. Burgert, Mary Savoye, Sonia Caprio · 2005 · Diabetes Care
  84. Insulin Resistance as an Independent Predictor of Cardiovascular Mortality in Patients with End-Stage Renal Disease
    Kayo Shinohara, Tetsuo Shoji, Masanori Emoto, Hideki Tahara, Hidenori Koyama, Eiji Ishimura, Takami Miki, Tsutomu Tabata, Yoshiki Nishizawà · 2002 · Journal of the American Society of Nephrology
  85. Intermittent Hypoxia Increases Insulin Resistance in Genetically Obese Mice
    Vsevolod Y. Polotsky, Jianguo Li, Naresh M. Punjabi, Arnon E. Rubin, Philip L. Smith, Alan R. Schwartz, Christopher Paul O'Donnell · 2003 · The Journal of Physiology
  86. Linkage of type 2 diabetes to the glucokinase gene
    Andrew Tym Hattersley, R. C. Turner, P. Patel, Stephen O’Rahilly, Andrew Tym Hattersley, P. Patel, J. S. Wainscoat, M. Alan Permutt, Y Tanazawa, K.C Chin et al. · 1992 · The Lancet
  87. Insulin resistance is a cause of steatosis and fibrosis progression in chronic hepatitis C
    Lætitia Fartoux, Armelle Poujol‐Robert, Jérôme Guechot, Dominique Wendum, Raoul Y. Poupon, Lawrence Serfaty · 2005 · Gut
  88. Clinical value of the metabolic syndrome for long term prediction of total and cardiovascular mortality: prospective, population based cohort study
    Johan Sundström, Ulf Risérus, Liisa Byberg, Björn Zethelius, Hans Lithell, Lars Lind · 2006 · BMJ
  89. Coronary risk factors in people from the Indian subcontinent living in West London and their siblings in India
    Deven J. Patel, M. Winterbotham, R P Britt, G.C. Sutton, Deepak Bhatnagar, Mike Mackness, Francis H Creed, Barbara Tomenson, Paul N. Durrington, Inder S. Anand et al. · 1995 · The Lancet
  90. Gender differences in cardiovascular disease
    Zujie Gao, Zengsheng Chen, Anqiang Sun, Xiaoyan Deng · 2019 · Medicine in Novel Technology and Devices
  91. Calcium Plus Vitamin D Supplementation and the Risk of Incident Diabetes in the Women's Health Initiative
    Ian H. de Boer, Lesley Fels Tinker, Stephanie Connelly, J. David Curb, Barbara V. Howard, Bryan R. Kestenbaum, Joseph C. Larson, JoAnn E. Manson, Karen L. Margolis, David S. Siscovick et al. · 2008 · Diabetes Care
  92. Genome-Wide Association Identifies Nine Common Variants Associated With Fasting Proinsulin Levels and Provides New Insights Into the Pathophysiology of Type 2 Diabetes
    Strawbridge, Rona J., Dupuis, Josée, Prokopenko, Inga, Barker, Adam, Ahlqvist, Emma, Rybin, Denis, Petrie, John R., Travers, Mary E., Bouatia-Naji, Nabila, Dimas, Antigone S. et al. · 2011 · Diabetes
  93. Prevention of Type II diabetes in subjects with impaired glucose tolerance: the Diabetes Prevention Study (DPS) in Finland
    Eriksson, J., Lindström, J., Valle, T., Aunola, S., Hämäläinen, H., Ilanne-Parikka, P., Keinänen-Kiukaanniemi, S., Laakso, M., Lauhkonen, M., Lehto, P. et al. · 1999 · Diabetologia
  94. Correlation between Serum Resistin Level and Adiposity in Obese Individuals
    Koichiro Azuma, Fuminori Katsukawa, Shuji Oguchi, Mitsuru Murata, Hajime Yamazaki, Akira Shimada, Takao Saruta · 2003 · Obesity Research
  95. Adipose Tissue Has Aberrant Morphology and Function in PCOS: Enlarged Adipocytes and Low Serum Adiponectin, but Not Circulating Sex Steroids, Are Strongly Associated with Insulin Resistance
    Mannerås-Holm, Louise, Leonhardt, Henrik, Kullberg, Joel, Jennische, Eva, Odén, Anders, Holm, Göran, Hellström, Mikael, Lönn, Lars, Olivecrona, Gunilla, Stener-Victorin, Elisabet et al. · 2011 · The Journal of Clinical Endocrinology &amp; Metabolism
  96. Metformin in the treatment of non-alcoholic steatohepatitis: a pilot open label trial
    Nair, S., Diehl, A. M., Wiseman, M., Farr, G. H., Perrillo, R. P. · 2004 · Alimentary Pharmacology &amp; Therapeutics
  97. RETRACTED: CPAP for the Metabolic Syndrome in Patients with Obstructive Sleep Apnea
    Surendra Kumar Sharma, Swastik Agrawal, Deepak Damodaran, Vishnubhatla Sreenivas, Tamilarasu Kadhiravan, Lakshmy Ramakrishnan, Priya Jagia, Atin Kumar · 2011 · New England Journal of Medicine · Retracted
  98. Pioglitazone hydrochloride in combination with metformin in the treatment of type 2 diabetes mellitus: A randomized, placebo-controlled study
    DANIEL F. EINHORN, Marc Rendell, James L. Rosenzweig, John W Egan, Annette L Mathisen, Roberta L Schneider · 2000 · Clinical Therapeutics
  99. Novel Metabolic Risk Factors for Incident Heart Failure and Their Relationship With Obesity
    Hossein Bahrami, David A. Bluemke, Richard A. Kronmal, Alain Gerald Bertoni, Donald M. Lloyd‐Jones, Eyal Shahar, Moysés Szklo, João A.C. Lima · 2008 · Journal of the American College of Cardiology
  100. Laparoscopic Adjustable Gastric Banding in Severely Obese Adolescents
    Paul E. O’Brien, Susan Margaret Sawyer, Cheryl Laurie, Wendy A. Brown, Stewart A. Skinner, Friederike C M Veit, Eldho Mathew Paul, Paul Robert Burton, Melanie A. McGrice, Margaret Anderson et al. · 2010 · JAMA